Atlas Trials

Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients

Clinical trial NCT00558961 · TERMINATED

Trial details

NCT number
NCT00558961
Sponsor
Jewish General Hospital
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic Leukemia
Start date
2005-10-01
Primary completion
2009-04-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.